Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (toxin A), and tcdB (toxin B) genes for toxigenic culture of Clostridium difficile

Journal of Clinical Microbiology

Volumn 42, Issue 12, 2004, Pages 5710-5714

  Lemee, Ludovic ^a,b   Dhalluin, Anne ^a,b   Testelin, Sabrina ^a,b   Mattrat, Marie Andre ^a,b   Maillard, Karine ^c   Lemeland, Jean François ^a,b   Pons, Jean Louis ^a,b,d  

^a UNIVERSITÉ DE ROUEN   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c Frank Duncombe Laboratory   (France)

^d UNIVERSITÉ DE ROUEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TOXIN; TRIOSEPHOSPHATE ISOMERASE;

ARTICLE; CLOSTRIDIUM DIFFICILE; FECES ANALYSIS; GENE AMPLIFICATION; IMMUNOASSAY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TOXICITY;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CULTURE MEDIA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXINS; FECES; HUMANS; POLYMERASE CHAIN REACTION; TRIOSE-PHOSPHATE ISOMERASE;

ANIMALIA; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; POSIBACTERIA;

EID: 10844293286     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.12.5710-5714.2004     Document Type: Article

References (29)

1. al-Barrak, A., J. Embil, B. Dyck, K. Olekson, D. Nicoll, M. Alfa, and A. Kabani, 1999. An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital. Can. Commun. Dis. Rep. 25:65-69.
2. Alfa, M. J., A. Kabani, D. Lyerly, S. Moncrief, L. M. Neville, A. Al-Barrak, G. K. Harding, B. Dyck, K. Olekson, and J. M. Embil. 2000. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J. Clin. Microbiol. 38:2706-2714.
3. Barbut, F., C. Kajzer, N. Planas, and J. C. Petit. 1993. Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea. J. Clin. Microbiol. 31:963-967.
4. Barbut, F., V. Lalande, B. Burghoffer, H. V. Thien, E. Grimprel, and J. C. Petit. 2002. Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France. J. Clin. Microbiol. 40:2079-2083.
5. Bartlett, J. G., T. W. Chang, M. Gurwith, S. L. Gorbach, and A. B. Onderdonk. 1978. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N. Engl. J. Med. 298:531-534.
6. Bartlett, J. G., N. Moon, T. W. Chang, N. Taylor, and A. B. Onderdonk. 1978. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology 75:778-782.
7. Baverud, V., A. Gustafsson, A. Franklin, A. Aspan, and A. Gunnarsson. 2003. Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility. Equine Vet. J. 35:465-471.
8. Brazier, J. S. 1998. The diagnosis of Clostridium difficile-associated disease. J. Antimicrob. Chemother. 41(Suppl. C):29-40.
9. Brazier, J. S., S. L. Stubbs, and B. I. Duerden. 1999. Prevalence of toxin A negative/B positive Clostridium difficile strains. J. Hosp. Infect. 42:248-249.
10. Chaves-Olarte, E., P. Low, E. Freer, T. Norlin, M. Weidmann, C. von Eichel-Streiber, and M. Thelestam. 1999. A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two other large clostridial cytotoxins. J. Biol Chem. 274:11046-11052.
11. Collins, M. D., P. A. Lawson, A. Willems, J. J. Cordoba, J. Fernandez-Garayzabal, P. Garcia, J. Cai, H. Hippe, and J. A. Farrow. 1994. The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int. J. Syst. Bacteriol. 44:812-826.
12. Delmee, M. 2001. Laboratory diagnosis of Clostridium difficile disease. Clin. Microbiol. Infect. 7:411-416.
13. Dhalluin, A., L. Lemee, M. Pestel-Caron, F. Mory, G. Leluan, J. F. Lemeland, and J. L. Pons. 2003. Genotypic differentiation of twelve Clostridium species by polymorphism analysis of the triosephosphate isomerase (tpi) gene. Syst. Appl. Microbiol. 26:90-96.
14. Donaldson, M. T., and J. E. Palmer. 1999. Prevalence of Clostridium perfringens enterotoxin and Clostridium difficile toxin A in feces of horses with diarrhea and colic. J. Am. Vet. Med. Assoc. 215:358-361.
15. Frey, S. M., and T. D. Wilkins. 1992. Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A. Infect. Immun. 60:2488-2492.
16. Gerding, D. N., M. M. Olson, L. R. Peterson, D. G. Teasley, R. L. Gebhard, M. L. Schwartz, and J. T. Lee, Jr. 1986. Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch. Intern. Med. 146:95-100.
17. Holdeman, L. V., E. P. Cato, and W. E. C. Moore (ed.). 1977. Anaerobe laboratory manual, 4th ed. Virginia Polytechnic Institute and State University, Blacksburg, Va.
18. Kato, H., N. Kato, K. Watanabe, N. Iwai, H. Nakamura, T. Yamamoto, K. Suzuki, S. M. Kim, Y. Chong, and E. B. Wasito. 1998. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J. Clin. Microbiol. 36:2178-2182.
19. Komatsu, M., H. Kato, M. Aihara, K. Shimakawa, M. Iwasaki, Y. Nagasaka, S. Fukuda, S. Matsuo, Y. Arakawa, M. Watanabe, and Y. Iwatani. 2003. High frequency of antibiotic-associated diarrhea due to toxin A-negative, toxin B-positive Clostridium difficile in a hospital in Japan and risk factors for infection. Eur. J. Clin. Microbiol. Infect. Dis. 22:525-529.
20. Lemee, L., A. Dhalluin, M. Pestel-Caron, J. F. Lemeland, and J. L. Pons, 2004. Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types. J. Clin. Microbiol. 42:2609-2617.
21. + strain of Clostridium difficile. J. Clin. Microbiol. 38:1696-1697.
22. Lozniewski, A., C. Rabaud, E. Dotto, M. Weber, and F. Mory. 2001. Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of Premier Cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains. J. Clin. Microbiol. 39:1996-1998.
23. Lyerly, D. M., H. C. Krivan, and T. D. Wilkins. 1988. Clostridium difficile: its disease and toxins. Clin. Microbiol. Rev. 1:1-18.
24. Lyerly, D. M., L. M. Neville, D. T. Evans, J. Fill, S. Allen, W. Greene, R. Sautter, P. Hnatuck, D. J. Torpey, and R. Schwalbe. 1998. Multicenter evaluation of the Clostridium difficile TOX A/B TEST. J. Clin. Microbiol. 36:184-190.
25. Riley, T. V., J. E. Adams, G. L. O'Neill, and R. A. Bowman. 1991. Gastrointestinal carriage of Clostridium difficile in cats and dogs attending veterinary clinics. Epidemiol. Infect. 107:659-665.
26. Rupnik, M., V. Avesani, M. Janc, C. von Eichel-Streiber, and M. Delmee. 1998. A novel toxinotyping scheme and correlation of toxinotypes with sero-groups of Clostridium difficile isolates. J. Clin. Microbiol. 36:2240-2247.
27. Sambol, S. P., M. M. Merrigan, D. Lyerly, D. N. Gerding, and S. Johnson. 2000. Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease. Infect. Immun. 68:5480-5487.
28. Samra, Z., S. Talmor, and J. Bahar. 2002. High prevalence of toxin A-negative toxin B-positive Clostridium difficile in hospitalized patients with gastrointestinal disease. Diagn. Microbiol. Infect. Dis. 43:189-192.
29. Turgeon, D. K., T. J. Novicki, J. Quick, L. Carlson, P. Miller, B. Ulness, A. Cent, R. Ashley, A. Larson, M. Coyle, A. P. Llmaye, B. T. Cookson, and T. R. Pritsche. 2003. Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay. J. Clin. Microbiol. 41:667-670.